Related Experiment Video
Updated: Aug 11, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
CC chemokine receptor (CCR)-2 prevents arthritis development following infection by Mycobacterium avium
Marlon P Quinones1, Fabio Jimenez, Hernan Martinez
1South Texas Veterans Health Care System, Audie L. Murphy Division, San Antonio, Veterans Administration Center for Research on AIDS and HIV-1 Infection, San Antonio, TX, USA.
Abstract:
The host factors that influence autoimmune arthritides such as rheumatoid arthritis have not been fully elucidated. We previously found that genetic inactivation of CC chemokine receptor 2 (CCR2) in the arthritis-prone DBA/1j mouse strain significantly increases the susceptibility of this strain to autoimmune arthritis induced by immunization with collagen type II (CII) and complete Freund's adjuvant (CFA). Here, we show that following intradermal infection with Mycobacterium avium, a similar arthritis phenotype was detected in Ccr2-null mice in the DBA/1j, but not in the BALB/c background. The failure to develop arthritis in Ccr2-null BALB/c mice occurred in the face of high bacterial burdens and low interferon gamma (IFNgamma) production. By contrast, Ccr2-null DBA/1j mice had low bacterial burdens, produced normal amounts of IFNgamma, and had high titers of autoantibodies against CII. Thus, the Ccr2-null state in an arthritic-prone genetic background leads to increased arthritis susceptibility following infectious (M. avium) and noninfectious (CII/CFA) challenges. Because CCR2 serves as a negative regulator of murine arthritis, caution might need to be exercised while testing CCR2 blockers in human arthritis or other diseases. These findings also indicate that Ccr2-null DBA/1j mice might serve as a valuable model system to uncover the immunological determinants of arthritis and to test novel antiarthritic agents.
Insights
Genetic inactivation of CC chemokine receptor 2 (CCR2) increases arthritis susceptibility in DBA/1j mice. This suggests CCR2 negatively regulates murine arthritis, impacting potential human therapies.
Area of Science:
- Immunology
- Rheumatology
- Genetics
Background:
- Host factors influencing autoimmune arthritis remain incompletely understood.
- Previous studies indicated CC chemokine receptor 2 (CCR2) genetic inactivation increases arthritis susceptibility in DBA/1j mice.
- The role of CCR2 in autoimmune disease pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate the role of CCR2 in autoimmune arthritis development following infectious and non-infectious challenges.
- To compare arthritis phenotypes in Ccr2-null mice on different genetic backgrounds (DBA/1j vs. BALB/c).
- To evaluate the potential of Ccr2-null DBA/1j mice as a model for arthritis research.
Main Methods:
- Induction of arthritis via collagen type II (CII) and complete Freund's adjuvant (CFA) immunization.
- Intradermal infection with Mycobacterium avium in Ccr2-null and wild-type mice on DBA/1j and BALB/c backgrounds.
- Assessment of arthritis phenotype, bacterial burden, interferon gamma (IFNgamma) production, and autoantibody titers.
Main Results:
- Ccr2-null DBA/1j mice exhibited increased susceptibility to arthritis after both CII/CFA and M. avium challenges.
- Ccr2-null BALB/c mice failed to develop arthritis despite high bacterial burdens and low IFNgamma production.
- Ccr2-null DBA/1j mice showed low bacterial burdens, normal IFNgamma, and high anti-CII autoantibody titers.
Conclusions:
- CCR2 acts as a negative regulator of murine arthritis, with its absence exacerbating disease in a genetically susceptible background.
- Findings suggest caution in developing CCR2 blockers for human arthritis and related diseases.
- Ccr2-null DBA/1j mice represent a valuable model for studying arthritis immunopathogenesis and evaluating anti-arthritic agents.
More Related Videos
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway

